^
Association details:
| Biomarker: | G0S2 overexpression |
|---|---|
| Cancer: | Chronic Myeloid Leukemia |
| Drug: | imatinib (YD312) (c-KIT inhibitor, SCF signal transduction pathway inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Abstract 648: Role of G0S2 in chronic myeloid leukemia and TKI resistance
Published date:
06/23/2020
Excerpt:
Retrospective analysis of survival data for patients whose samples were evaluated in a microarray revealed that high G0S2 expression (>50%) correlated with a longer overall survival (n=30 responders, n=16 non-responders, p=0.036).
DOI:
10.1158/1538-7445.AM2020-648
